ESC Premium Access

From trials to clinical use: transcatheter interventions in secondary mitral regurgitation

Event: ESC CONGRESS 2019
Topic: Valvular Heart Disease
Session type: Advances in Science
Date: 1 September 2019
Time: 11:00 - 12:30

Congress Session

5 presentations in this session

State of the Art - Review of current evidence for transcatheter interventions in secondary mitral regurgitation

Speaker: Professor S. Kapadia (Cleveland, US)

MitraClip treatment of functional mitral regurgitation - A meta-analysis

Speaker: Assistant Professor M. Noutsias (Neuruppin, DE)

Combined tricuspid and mitral vs. isolated mitral valve repair for severe mitral and tricuspid regurgitation: An analysis from TriValve and TRAMI registries

Speaker: Mr M. Mehr (Munich, DE)

Reduction of mitral regurgitation in patients with heart failure and secondary mitral regurgitation: relationship between changes in brain natriuretic peptide and outcomes from the COAPT trial

Speaker: Doctor G. Stone (New York, US)

Surgical vs. catheter-based treatment of mitral regurgitation in 2030

Speaker: Professor F. Maisano (Milano, IT)

5 speakers from this session

Professor Samir R Kapadia

Cleveland Clinic Foundation, Cleveland (United States of America)
8 presentations
0 follower

Assistant Professor Michel Noutsias

Brandenburg Medical School Theodor Fontane, Neuruppin (Germany)
4 presentations
0 follower

Mr Michael Mehr

University Hospital of Munich, Munich (Germany)
0 follower

Doctor Gregg Stone

Icahn School of Medicine at Mount Sinai, New York (United States of America)
13 presentations
0 follower

Professor Francesco Maisano

Ospedale San Raffaele, Milano (Italy)
43 presentations

This platform is supported by

logo Novo Nordisk